» Articles » PMID: 3241122

Plasma Very Low Density Lipoproteins Contain a Single Molecule of Apolipoprotein B

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 1988 Nov 1
PMID 3241122
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Rat and human very low density lipoproteins (VLDL) were fractionated by zonal ultracentrifugation, yielding sharply defined fractions with narrow sedimentation limits. Sedimentation coefficients for the individual fractions were determined at two densities with the analytical ultracentrifuge, and the results were analyzed to yield buoyant densities and molecular weights for the particles in each fraction. For the rat lipoproteins, the weight concentrations of triglycerides, cholesterol, phospholipid, and protein were determined for each fraction, and their molar concentrations of apolipoprotein B were measured with a radioimmunoassay. For the human lipoproteins the corresponding values were taken from Patsch et al. (Patsch, W., J. R. Patsch, G. M. Kostner, S. Sailer, and H. Braunsteiner. 1978. Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation. J. Biol. Chem. 253:4911-4915). From these data, a ratio of the number of apoB peptides to the number of lipoprotein particles was calculated for each fraction. This ratio was close to 1 for all VLDL fractions, ranging in particle diameter from about 40 to 80 mm and 30 to 50 mm, respectively, for rat and human VLDL. The majority rat VLDL contain B-48 rather than B-100 as their (single) apoB peptide. Based on these data, we proposed that only a single copy of B-48 is required for VLDL assembly in rat liver, unless nascent hepatic VLDL contain additional apoB peptides which are uniformly lost from the plasma VLDL particles when they are analyzed.

Citing Articles

Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer.

Li C, Yang X, Zhong Y, Wang W, Jin X, Bian L Transl Oncol. 2024; 51:102208.

PMID: 39591897 PMC: 11629317. DOI: 10.1016/j.tranon.2024.102208.


Gene transfer and genome editing for familial hypercholesterolemia.

Canepari C, Cantore A Front Mol Med. 2024; 3:1140997.

PMID: 39086674 PMC: 11285693. DOI: 10.3389/fmmed.2023.1140997.


Apolipoprotein B and Lipid Profile in Italian Children and Adolescents.

Martino F, Niglio T, Martino E, Paravati V, de Sanctis L, Guardamagna O J Cardiovasc Dev Dis. 2024; 11(2).

PMID: 38392258 PMC: 10889147. DOI: 10.3390/jcdd11020044.


MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research.

Lucien F, Gustafson D, Lenassi M, Li B, Teske J, Boilard E J Extracell Vesicles. 2023; 12(12):e12385.

PMID: 38063210 PMC: 10704543. DOI: 10.1002/jev2.12385.


Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?.

Cole J, Zubiran R, Wolska A, Jialal I, Remaley A J Clin Med. 2023; 12(17).

PMID: 37685804 PMC: 10488498. DOI: 10.3390/jcm12175737.